Scott Glickman
Medical Director & Chairman, UroPharma


UroPharma was founded to exploit an unmet need in bladder therapeutics with drug-delivery combinations that will further enhance and expand the field of intravesical or direct to bladder treatments.

The dtb-instilla is a drug delivery system that consists of a single-use disposable device that dispenses a precise dose of the medication directly into the bladder.

As pioneers in this potentially vast field of evolving treatments, in order to meet patients’ clinical needs, UroPharma aims to become the leader in the global intravesical therapeutics market.

Matchmaking Information

Processing. Please wait.